LATEST TRIALS

  • Lung Cancer
    A Phase II Multi Center Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Adenocarcinoma of the Lung
  • Leukemia
    Phase 1b, multi-arm, open-label study of PDR001 and/or MBG453 in combination with decitabine in patients with acute myeloid leukemia or high risk myelodysplastic syndrome
  • Head And Neck Cancer
    REPORT; REirradiation and PD-1 blockade On Recurrent squamous cell head and neck Tumors

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen